查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1592917

吸入治疗市场雾化器：按类型、应用和最终用户划分 - 全球预测 2025-2030

Inhalation Therapy Nebulizer Market by Type (Atomizer Jet, Ultrasonic Nebulizers), Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年吸入治疗雾化器市值为23.9亿美元，预计2024年将达25.8亿美元，复合年增长率为7.79%，预计到2030年将达到40.5亿美元。

吸入治疗雾化器市场包括主要用于吸入肺部的雾化药物的设备，这对于治疗气喘、慢性阻塞性肺病和囊肿纤维化等呼吸系统疾病非常重要。雾化器的需求在于其能够快速、有效、直接地将药物输送到呼吸道，这对于慢性呼吸道疾病患者至关重要。雾化器有着广泛的应用，包括医院、诊所和居家医疗，这使得它们对于呼吸系统疾病的治疗至关重要。该市场涵盖广泛的重要最终用途应用，从紧急医院护理到长期家庭管理。

主要市场统计
基准年[2023] 23.9亿美元
预测年份 [2024] 25.8亿美元
预测年份 [2030] 40.5亿美元
复合年增长率（%） 7.79%

该市场受到多种因素的推动，包括全球呼吸系统疾病的盛行率不断上升、人口老化变得更容易患此类疾病，以及雾化器设备技术进步提高疗效和患者舒适度等关键成长要素的影响。随着新兴市场的成长，护理服务的改善正在增加雾化器的采用，也存在为不断扩大的居家照护行业开发携带式、易于使用的设备的机会。利用这些机会的建议包括专注于创新进步，例如与健康监测应用程式和设备配合使用的智慧雾化器，这些设备结合了患者回馈机制，以提高治疗依从性。

影响市场成长的挑战包括与先进雾化器型号相关的高成本、吸入器等替代吸入设备的竞争以及医疗设备的严格监管要求，特别是在高度监管的市场中。此外，低收入地区的认知度和可及性较低也造成了限制，从而为采用造成了障碍。创新机会在于提高设备的便携性、将人工智慧整合到个人化治疗计划以及延长行动使用的电池寿命。透过增加研发投资以及旨在扩大准入和降低成本的伙伴关係，市场有望成长，对于愿意适应监管环境并响应以用户为中心的需求的公司来说，竞争非常激烈，这表明资源丰富的环境。

市场动态：快速发展的吸入治疗雾化器市场的关键市场洞察

供需的动态交互作用正在改变吸入治疗雾化器市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性呼吸道疾病增加
    • 家庭医疗保健设备需求
    • 患有各种疾病的老年人口不断增加
  • 市场限制因素
    • 吸入治疗雾化器对健康的副作用
  • 市场机会
    • 使用雾化器吸入治疗糖尿病等其他疾病
    • 透过卫生政策提高吸入治疗雾化器的认识
  • 市场挑战
    • 单一有效吸入装置的可用性低

波特五力：驾驭吸入治疗雾化器市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解吸入治疗雾化器市场的外部影响

外部宏观环境因素在塑造吸入治疗雾化器市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解吸入治疗雾化器市场的竞争状况

对吸入治疗雾化器市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵吸入治疗雾化器市场供应商绩效评估

FPNV定位矩阵是评估吸入治疗雾化器市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了吸入治疗雾化器市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，吸入治疗雾化器市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性呼吸道疾病盛行率上升
      • 需要家庭健康设备
      • 患有各种疾病的老年人口不断增加
    • 抑制因素
      • 吸入治疗雾化器对健康的副作用
    • 机会
      • 使用雾化器吸入治疗其他类型的疾病，例如糖尿病
      • 透过支持性健康政策提高对吸入治疗雾化器的认识
    • 任务
      • 有效吸入器的可得性不足
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章吸入治疗雾化器市场：依类型

  • 雾化器喷射
  • 超音波雾化器

第七章吸入治疗雾化器市场：依应用分类

  • 气喘
  • 慢性阻塞性肺病
  • 囊肿纤维化
  • 鼻塞

第八章吸入治疗雾化器市场：依最终用户分类

  • 门诊手术中心
  • 居家照护中心
  • 医院

第九章美洲吸入治疗雾化器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太吸入治疗雾化器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲吸入治疗雾化器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • A&D Company, Limited
  • Agilent Technologies, Inc.
  • Air Liquide Medical Systems SA
  • AptarGroup, Inc.
  • Boehringer Ingelheim International GmbH
  • DeVilbiss Healthcare GmbH
  • GF Health Products, Inc.
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronics PLC
  • Omron Corporation
  • PARI GmbH
  • Pfizer Inc.
  • Trudell Medical International
  • Vyaire Medical Inc.
Product Code: MRR-43127F727985

The Inhalation Therapy Nebulizer Market was valued at USD 2.39 billion in 2023, expected to reach USD 2.58 billion in 2024, and is projected to grow at a CAGR of 7.79%, to USD 4.05 billion by 2030.

The inhalation therapy nebulizer market involves devices used primarily for administering medication in the form of a mist inhaled into the lungs, critical in treating respiratory diseases like asthma, COPD, and cystic fibrosis. The necessity of nebulizers lies in their ability to deliver medication quickly, effectively, and directly to the respiratory tract, which is essential for patients with chronic respiratory disorders. Their application extends across hospitals, clinics, and homecare settings, making them integral to managing respiratory illnesses. The market sees significant end-use across these various settings, demonstrating a broad scope from acute hospital care to chronic management at home.

KEY MARKET STATISTICS
Base Year [2023] USD 2.39 billion
Estimated Year [2024] USD 2.58 billion
Forecast Year [2030] USD 4.05 billion
CAGR (%) 7.79%

The market is influenced by several key growth factors, including the increasing incidence of respiratory diseases globally, an aging population more susceptible to such conditions, and technological advancements in nebulizer devices improving efficacy and patient comfort. Opportunities exist in the development of portable, user-friendly devices that cater to a growing home care sector, alongside growth in emerging markets where increasing healthcare access is raising nebulizer adoption. Recommendations for capitalizing on these opportunities include focusing on innovative advancements such as smart nebulizers that connect with health monitoring apps and devices that incorporate patient feedback mechanisms for improved treatment adherence.

Challenges affecting market growth include high costs associated with advanced nebulizer models, competition from alternative inhalation devices like inhalers, and stringent regulatory requirements for medical devices, particularly in highly-regulated markets. Limitations also arise from a lack of awareness and accessibility in low-income regions, presenting barriers to adoption. Innovation opportunities lie in enhancing device portability, integrating AI for personalized treatment plans, and improving battery life for mobile use. The market is poised for growth through increased investment in R&D and partnerships aiming to expand access and reduce costs, indicating a highly competitive yet opportunity-rich environment for businesses willing to navigate regulatory landscapes and address user-centric demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Inhalation Therapy Nebulizer Market

The Inhalation Therapy Nebulizer Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalences of chronic respiratory diseases
    • Need for home healthcare devices
    • Increasing geriatric population with various disease
  • Market Restraints
    • Side effects of inhalation therapy nebulizer on the health
  • Market Opportunities
    • Use of inhalation therapy nebulizer in other kinds of diseases such as diabetes
    • Increasing awareness about the inhalation therapy nebulizer with supportive health policies
  • Market Challenges
    • Less availability of single effective inhaler devices

Porter's Five Forces: A Strategic Tool for Navigating the Inhalation Therapy Nebulizer Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Inhalation Therapy Nebulizer Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Inhalation Therapy Nebulizer Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Inhalation Therapy Nebulizer Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Inhalation Therapy Nebulizer Market

A detailed market share analysis in the Inhalation Therapy Nebulizer Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Inhalation Therapy Nebulizer Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Inhalation Therapy Nebulizer Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Inhalation Therapy Nebulizer Market

A strategic analysis of the Inhalation Therapy Nebulizer Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Inhalation Therapy Nebulizer Market, highlighting leading vendors and their innovative profiles. These include A&D Company, Limited, Agilent Technologies, Inc., Air Liquide Medical Systems SA, AptarGroup, Inc., Boehringer Ingelheim International GmbH, DeVilbiss Healthcare GmbH, GF Health Products, Inc., Johnson & Johnson, Koninklijke Philips N.V., Medtronics PLC, Omron Corporation, PARI GmbH, Pfizer Inc., Trudell Medical International, and Vyaire Medical Inc..

Market Segmentation & Coverage

This research report categorizes the Inhalation Therapy Nebulizer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Atomizer Jet and Ultrasonic Nebulizers.
  • Based on Application, market is studied across Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, and Nasal Congestion.
  • Based on End User, market is studied across Ambulatory Surgery Centers, Home Care Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalences of chronic respiratory diseases
      • 5.1.1.2. Need for home healthcare devices
      • 5.1.1.3. Increasing geriatric population with various disease
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of inhalation therapy nebulizer on the health
    • 5.1.3. Opportunities
      • 5.1.3.1. Use of inhalation therapy nebulizer in other kinds of diseases such as diabetes
      • 5.1.3.2. Increasing awareness about the inhalation therapy nebulizer with supportive health policies
    • 5.1.4. Challenges
      • 5.1.4.1. Less availability of single effective inhaler devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Inhalation Therapy Nebulizer Market, by Type

  • 6.1. Introduction
  • 6.2. Atomizer Jet
  • 6.3. Ultrasonic Nebulizers

7. Inhalation Therapy Nebulizer Market, by Application

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. Chronic Obstructive Pulmonary Disease
  • 7.4. Cystic Fibrosis
  • 7.5. Nasal Congestion

8. Inhalation Therapy Nebulizer Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Home Care Centers
  • 8.4. Hospitals

9. Americas Inhalation Therapy Nebulizer Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Inhalation Therapy Nebulizer Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Inhalation Therapy Nebulizer Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A&D Company, Limited
  • 2. Agilent Technologies, Inc.
  • 3. Air Liquide Medical Systems SA
  • 4. AptarGroup, Inc.
  • 5. Boehringer Ingelheim International GmbH
  • 6. DeVilbiss Healthcare GmbH
  • 7. GF Health Products, Inc.
  • 8. Johnson & Johnson
  • 9. Koninklijke Philips N.V.
  • 10. Medtronics PLC
  • 11. Omron Corporation
  • 12. PARI GmbH
  • 13. Pfizer Inc.
  • 14. Trudell Medical International
  • 15. Vyaire Medical Inc.

LIST OF FIGURES

  • FIGURE 1. INHALATION THERAPY NEBULIZER MARKET RESEARCH PROCESS
  • FIGURE 2. INHALATION THERAPY NEBULIZER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INHALATION THERAPY NEBULIZER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INHALATION THERAPY NEBULIZER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INHALATION THERAPY NEBULIZER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INHALATION THERAPY NEBULIZER MARKET DYNAMICS
  • TABLE 7. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ATOMIZER JET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY NASAL CONGESTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY HOME CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. INHALATION THERAPY NEBULIZER MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. INHALATION THERAPY NEBULIZER MARKET, FPNV POSITIONING MATRIX, 2023